CompletedNCT02549222
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cerus Corporation
- Principal Investigator
- Edward L Snyder, MDYale New Haven Hospital
- Intervention
- Standard of Care(other)
- Enrollment
- 2291 target
- Eligibility
- All sexes
- Timeline
- 2015 – 2021
Study locations (15)
- UCLA Medical Center, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- Yale-New Haven Hospital, New Haven, Connecticut, United States
- Emory University, Atlanta, Georgia, United States
- University of Maryland, Baltimore, Maryland, United States
- Beth Israel, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- St. Louis Children's Hospital, St Louis, Missouri, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- Memorial Sloan Kettering, New York, New York, United States
- Strong Memorial Hospital, Rochester, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- East Carolina University Hospital, Greenville, North Carolina, United States
- TriHealth Cancer Institute, Cincinnati, Ohio, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02549222 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer